企業プロフィール

Simulations Plus 株価・ニュース・カタリスト

ティッカー:
SLP
取引所:
NASDAQ
セクター:
Biopharma
所在地:
United States

株価パフォーマンス

18.40 USD (0.00%)

終値

最終更新: 2026年8月24日

339M USD

時価総額

株価変動の要因

As of Aug 24, 2026, SLP was little changed and closed at $18.40. No new same-company headline was identified in the current news window.

企業概要

事業概要

Simulations Plus is a software company that provides modeling, simulation, and workflow tools for drug development. Its value lies in helping biopharma customers make better development decisions.

所在地とセクター分類

Headquartered in the United States and listed on NASDAQ, Simulations Plus sits in pharma software and development tools.

ビジネスモデルの特徴

The company depends on software subscriptions, services, and continued adoption by drug developers and regulators.

バイオ業界での位置付け

Simulations Plus is an important biotech-enabling software name, not a drug company itself.

今後のカタリスト

  • Simulations Plus's catalysts are software bookings, biosimulation demand, and AI-driven workflow adoption in pharma development. Investors will want to see whether the modeling platform stays embedded in drug development workflows.

最近のニュース

    類似銘柄

    事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。